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Background
Botulinum toxin type A (BTX-A) has been used for pro-
phylactic treatment in chronic migraine. However, the
precise mechanism of its action is obscure. We previously
reported that the injection of BTX-A into the facial
ophthalmic nerve region reduced the number of the
TRPV1-immunoreactve (IR) neurons in the trigeminal
ganglion (TG). The dura mater, known as an important
site of headache generation, is densely innervated by tri-
geminal nociceptors. We have recently demonstrated the
existence of TRPV1-IR nerve fibers in the dura mater that
originate in TG. In this study, we explored the effect of
BTX-A on the number of the TRPV1-IR TG neurons
innervating the dura mater.
Methods
Six Sprague-Dawley rats were used. The retrograde tracer,
true blue (TB), was applied to the dura mater. Seven days
after the tracer application, 0.5 ng/kg BTX-A was injected
into the left side of the face in three animals, and three
control animals were injected with saline at the same loca-
tion. After 7 days, TGs were dissected out and immunos-
tained with an anti-TRPV1 antibody. For analysis, we
calculated the ratio of the TRPV1-IR cells in TB accumu-
lated neurons. Results In the control animals, the propor-
tion of TRPV1-IR-containing neurons that were also
TB-positive was 27 % (n = 372 neurons from 3 animals).
In the BTX-A treated animals, tracer accumulation and
TRPV1-IR were also observed. However, the number of
TRPV1-IR neurons retrogradely labeled with true blue
was reduced. The proportion of TRPV1-IR cells in the
BTX-A treated animals was 11 % (n = 504 neurons from
3 animals), and this was significantly decreased compared
to the control group (Student’s t-test, p < 0.0001).
Conclusion
Our results indicated the possibility that BTX-A may
reduce the expression of the TRPV1 receptor in neurons
of the TG innervating the dura mater, which may account
for its alleviating action against headache disorders.
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